Table 1 |
|
|
Clinical and laboratory features in 120 patients with rheumatoid arthritis (RA) |
|
|
Characteristics |
Values |
|
|
|
|
Age, yrs |
58.95 ± 1.12 |
|
Men/women |
33/87 |
|
Disease duration, yrs |
18.02 ± 8.98 |
|
DAS28 |
4.89 ± 0.09 |
|
ESR, mm/h |
60.86 ± 2.60 |
|
CRP, mg/l |
38.71 ± 4.03 |
|
RF-IgM-positive |
89 (74.17) |
|
RF-IgG-positive |
66 (55.00) |
|
RF-IgA-positive |
72 (60.00) |
|
Anti-CCP-positive |
65 (54.17) |
|
Treatment |
|
|
DMARDs |
9 (7.50) |
|
CS |
22 (18.33) |
|
CS+DMARDs |
41 (34.17) |
|
Others |
48 (40.00) |
|
|
|
|
Clinical characteristics are presented as mean ± SEM or number (%). DAS28, 28-joint count disease activity score; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; RF, rheumatoid factor; Anti-CCP, anti-cyclic citrullinated peptide antibody; CS, corticosteroid; DMARDs, disease-modifying antirheumatic drugs; Others, non-steroidal anti-inflammatory drugs, traditional Chinese medicine or never taking any medication. |
|
|
Liu et al. Arthritis Research & Therapy 2012 14:R255 doi:10.1186/ar4100 |
|
